"False"
Umeå universitet
printicon
Huvudmenyn dold.

Martin Erlanson

Kontakt

E-post
martin.erlanson@umu.se
Telefon
090-785 13 57

Verksam vid

Anknytning
Anknuten som läkare till Institutionen för strålningsvetenskaper Enhet: Onkologi
Plats
27C, Målpunkt QC31, Norrlands universitetssjukhus Umeå universitet, 901 87 Umeå
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma: is there a need for intervention in long-term survivors?
Upsala Journal of Medical Sciences, Upsala Medical Society 2021, Vol. 126
Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; et al.
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
American Journal of Hematology, Wiley-Blackwell 2020, Vol. 95, (1) : 57-67
Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; et al.
DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma
Blood Cancer Journal, Nature Publishing Group 2020, Vol. 10, (4)
Haider, Zahra; Landfors, Mattias; Golovleva, Irina; et al.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
British Journal of Haematology, John Wiley & Sons 2020, Vol. 188, (5) : 685-691
Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; et al.
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma
Bone Marrow Transplantation, NATURE PUBLISHING GROUP 2017, Vol. 52, (2) : 310-312
Ghez, D.; Fortpied, C.; Mounier, N.; et al.
STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA
Haematologica, Vol. 101, (S5) : 50-50
Ghez, D.; Fortpied, C.; Mounier, N.; et al.
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
Blood, Vol. 128, (23) : 2666-2670
Mansouri, Larry; Noerenberg, Daniel; Young, Emma; et al.
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
Leukemia, Vol. 29, (3) : 668-676
Junlen, H. R.; Peterson, S.; Kimby, E.; et al.
Follicular Lymphoma Survival in Sweden in the Rituximab Era
Blood, Vol. 124, (21)
Junlen, Henna Riikka; Peterson, Stefan; Kimby, Eva; et al.
A Phase I Study of (177)lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+Non-Hodgkin's B Cell Lymphoma
Blood, Vol. 124, (21)
Kolstad, Arne; Madsbu, Ulf; Dahle, Jostein; et al.
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Annals of Oncology, Vol. 24, (5) : 1385-1392
Holte, H.; Leppa, S.; Bjorkholm, M.; et al.
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
Journal of Clinical Oncology, Vol. 30, (25) : 3093-3099
d'Amore, Francesco; Relander, Thomas; Lauritzsen, Grete F.; et al.
Rituximab (R) in Combination with Interferon-a2a (IFN) Versus Single R in Patients with Follicular or Other CD20+Low-Grade (indolent) Lymphoma. Final Results From a Randomized Phase III Study From the Nordic Lymphoma Group
Blood, American Society of Hematology 2012, Vol. 120, (21)
Kimby, Eva; Östenstad, Björn; Brown, Peter de Nully; et al.
Long term risk of infections in Hodgkin lymphoma long-term survivors
British Journal of Haematology, Vol. 154, (5) : 661-663
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
High-dose chemotherapy and autologuos stem cell transplantation in previously untreated peripheral T-Cell Lymphoma: Final analysis of a large prospective multicenter study (NLG-T-01)
53rd ASH Annual Meeting and Exposition: Session: 731. Clinical Allogeneic and Autologous Transplantation - Results: Myeloma, Lymphomas and Multiple Sclerosis ; Monday, December 12, 2011: 7:00 AM Douglas Pavilion C (Manchester Grand Hyatt San Diego), washington, USA: American Society of Hematology 2011 : 155-156
d'Amore, Francesco; Relander, Thomas; Lauritzsen, Grete F.; et al.
Age-adjusted combined immunochemotherapy without radiotherapy in newly diagnosed PCNSL: A phase II trial of the Nordic Lymphoma Group
53rd ASH Anual Meeting and Exposition: Program: Oral and Poster AbstractsSession: 623. Lymphoma - Chemotherapy, excluding Pre-Clinical Models: Poster I Saturday, December 10, 2011, 5:30 PM-7:30 PM Hall GH (San Diego Convention Center) : 696-696
Pulczynski, Elisa Jacobsen; Kamper, Peter; Fagerli, Unn-Merete; et al.
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Clinical Cancer Research, American Association for Cancer Research 2011, Vol. 17, (12) : 4136-4144
Wahlin, Björn Engelbrekt; Sundström, Christer; Holte, Harald; et al.
Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden
Acta Oncologica, Vol. 47, (6) : 1029-1036
Kasteng, Frida; Erlanson, Martin; Hagberg, Hans; et al.
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
British Journal of Haematology, Wiley-Blackwell 2008, Vol. 141, (4) : 423-432
Linderoth, Johan; Edén, Patrik; Ehinger, Mats; et al.
Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
Modern Patholology, Vol. 20, (1) : 63-75
Berglund, Mattias; Enblad, Gunilla; Thunberg, Ulf; et al.
Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.
Br J Haematol, Vol. 138, (1) : 68-71
Hedström, Gustaf; Berglund, Mattias; Molin, Daniel; et al.
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Leuk Lymphoma, Vol. 48, (9) : 1774-1779
Linderoth, Johan; Ehinger, Mats; Jerkeman, Mats; et al.
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
Eur J Haematol, Vol. 79, (2) : 146-149
Linderoth, Johan; Ehinger, Mats; Åkerman, Måns; et al.
Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
Eur J Cancer, Vol. 40, (1) : 33-42
Linderholm, B; Andersson, J; Lindh, Birgitta; et al.
Telomerase activity in Hodgkin's disease
Blood, Vol. 92, (2) : 567-573
Norrback, Karl-Fredrik; Enblad, Gunilla; Erlanson, Martin; et al.
Cardiovascular side effects following treatment of Hodgkin’s lymphoma: comorbidity factors and a strategy for intervention
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
Epigenetic and genetic distinctions between T-cell acute lymphoblastic leukemia and lymphoma
Haider, Zahra; Landfors, Mattias; Golovleva, Irina; et al.
Visa publikationer i DiVA